Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Convalescent Plasma for COVID-19
NCT04327349Unknown
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Mar 2020
- Primary completion
- May 2020
- Modality
- Biologic
- Countries
- 1
01
Overview
Open-label, single-arm trial of convalescent plasma (Heinrich-Heine University, Duesseldorf) in coronavirus disease 2019 (COVID-19), sponsored by Mazandaran University of Medical Sciences. Primary endpoints: Mortality changes at 30 days, C-reactive protein at Day 7 and 3 more. Status: unknown.
02
Drugs
convalescent plasma (Heinrich-Heine University, Duesseldorf)
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04327349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04327349.